EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption gan Pinilla, Miriam, Mazars, Raoul, Vergé, Romain, Gorse, Leana, Paradis, Margaux, Suire, Bastien, Santoni, Karin, Robinson, Kim Samirah, Toh, Gee Ann, Prouvensier, Laure, Leon-Icaza, Stephen Adonai, Hessel, Audrey, Péricat, David, Murris, Marlène, Guet-Revillet, Hélène, Henras, Anthony, Buyck, Julien, Ravet, Emmanuel, Zhong, Franklin, Cougoule, Céline, Planès, Rémi, Meunier, Etienne

Pynciau: Cael y testun llawn

Elongation factor 2 in cancer: a promising therapeutic target in protein translation gan Xuechao Jia, Chuntian Huang, Fangfang Liu, Zigang Dong, Kangdong Liu

Pynciau: “...Elongation factor 2...”
Cael y testun llawn

2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies gan Gideon A. Shallangwa, PhD, Aliyu W. Mahmud, MSc, Adamu Uzairu, PhD, Muhmmad T. Ibrahim, PhD

Pynciau: Cael y testun llawn

Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549 gan WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing

Pynciau: “...lung adenocarcinoma|eukaryotic elongation factor 2 kinase|sodium tanshinone ⅱa sulfonate|proliferation|invasion...”
Cael y testun llawn